Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug 21;8(8):e74676.
doi: 10.1371/journal.pone.0074676. eCollection 2013.

HDL induces the expression of the M2 macrophage markers arginase 1 and Fizz-1 in a STAT6-dependent process

Marie Sanson  1 , Emilie Distel, Edward A Fisher
Affiliations

HDL induces the expression of the M2 macrophage markers arginase 1 and Fizz-1 in a STAT6-dependent process

Marie Sanson et al. PLoS One. .

Abstract

Our lab has previously shown in a mouse model that normalization of a low HDL level achieves atherosclerotic plaque regression. This included the shift from a pro ("M1") to an anti-inflammatory ("M2") phenotypic state of plaque macrophages. Whether HDL can directly cause this phenotypic change and, if so, what the signaling mechanism is, were explored in the present studies. Murine primary macrophages treated with HDL showed increased gene expression for the M2 markers Arginase-1 (Arg-1) and Fizz-1, which are classically induced by IL-4. HDL was able to potentiate the IL-4-induced changes in Arg-1, and tended to do the same for Fizz-1, while suppressing the expression of inflammatory genes in response to IFNγ. The effects of either IL-4 or HDL were suppressed when macrophages were from STAT6(-/-) mice, but inhibitor studies suggested differential utilization of JAK isoforms by IL-4 and HDL to activate STAT6 by phosphorylation. Overall, our results describe a new function of HDL, namely its ability to directly enrich macrophages in markers of the M2, anti-inflammatory, state in a process requiring STAT6.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. HDL promotes and enhances the expression of specific anti-inflammatory genes in primary macrophages.
BMDM were treated for 6h with HDL (50μg/mL), IL-4 (10ng/mL) or both. Gene expression of Arg-1 (A), Fizz-1 (B) and IL-4R (C) was assessed by real-time qPCR. Results are representative of four independent experiments. Asterisks indicate statistically significant differences, either compared to control, or between 2 conditions when linked by a bar (*p<0.05, **p<0.01).
Figure 2
Figure 2. HDL inhibits the basal and induced expression of pro-inflammatory genes in primary macrophages.
BMDM were treated for 6h with HDL (50μg/mL), IFNγ (10ng/mL) or both. Gene expression for iNOS (A), IL-6 (B) or TNFα (C) was assessed by real-time qPCR. Results are representative of three independent experiments. Asterisks indicate statistically significant differences, either compared to control, or between 2 conditions when linked by a bar (*p<0.05, **p<0.01, ***p<0.001).
Figure 3
Figure 3. HDL induces STAT6 phosphorylation and enhances IL-4-induced STAT6 activation, but has no effect on STAT3 phosphorylation status.
BMDM were grown as previously described and stimulated for 15min with either HDL alone (50μg/mL), IL-4 alone (10ng/mL) or both. Phosphorylation state for STAT6 (A) and STAT3 (C) was assessed by western blot. As a positive control for STAT3 activation, cells were treated with IL-10 (10ng/mL) for 30 min. Signal quantification for phospho-STAT6 (B) is the result of three independent experiments. Asterisks indicate statistically significant difference, either compared to control, or between 2 conditions when linked by a bar (*p<0.05, **p<0.01).
Figure 4
Figure 4. STAT6 inhibition affects macrophages alternative activation by HDL.
BMDM were isolated from STAT6+/+ (black bars) and STAT6-/- (hatched bars) mice and were stimulated for 6h with HDL (50μg/mL) or IL-4 (10ng/mL). The induction of Arg-1 or Fizz-1 mRNA in the STAT6+/+ cells by HDL was ~3X for each and by IL-4, ~1800 or 3300, respectively; these values were set to 100%. Results are representative of three independent experiments. Asterisks indicate statistically significant differences compared to corresponding STAT6+/+ conditions (***p<0.001).
Figure 5
Figure 5. Jak inhibition affects macrophages alternative activation by HDL.
BMDM were pre-treated for 2h with Jak pharmacological inhibitors (hatched bars. Ruxolitinib/Jak1/2 inhibitor: 1μM. TG101348/Jak2 inhibitor: 1μM: Kaempferol/Jak3 inhibitor: 40μM) or vehicle (black bars), and then treated for 6h with HDL (50μg/mL) or IL-4 (10ng/mL). Arg-1 (A, C, E) and Fizz-1 (B, D, F) expression are presented as the percentage of activation compared to non-inhibited conditions. The induction of Arg-1 and Fizz-1 by HDL was ~2X for each, and for IL-4 was >300 for Arg-1 and Fizz-1 and these values were set to 100%. Results are representative of three independent experiments. Asterisks indicate statistically significant differences compared to the vehicle-treated conditions (*p<0.05, **p<0.01, ***p<0.001).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Moore KJ, Tabas I (2011) Macrophages in the pathogenesis of atherosclerosis. Cell 145: 341-355. doi:10.1016/j.cell.2011.04.005. PubMed: 21529710. - DOI - PMC - PubMed
    1. Feig JE, Quick JS, Fisher EA (2009) The role of a murine transplantation model of atherosclerosis regression in drug discovery. Curr Opin Investig Drugs 10: 232-238. PubMed: 19333880. - PMC - PubMed
    1. Reis ED, Li J, Fayad ZA, Rong JX, Hansoty D et al. (2001) Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model. J Vasc Surg 34: 541-547. doi:10.1067/mva.2001.115963. PubMed: 11533609. - DOI - PubMed
    1. Llodrá J, Angeli V, Liu J, Trogan E, Fisher EA et al. (2004) Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci U S A 101: 11779-11784. doi:10.1073/pnas.0403259101. PubMed: 15280540. - DOI - PMC - PubMed
    1. Feig JE, Rong JX, Shamir R, Sanson M, Vengrenyuk Y et al. (2011) HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. Proc Natl Acad Sci U S A 108: 7166-7171. doi:10.1073/pnas.1016086108. PubMed: 21482781. - DOI - PMC - PubMed

Publication types